Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
5.47M
-
Shares change
-
+159K
-
Total reported value, excl. options
-
$186M
-
Value change
-
+$684K
-
Number of buys
-
46
-
Number of sells
-
-48
-
Price
-
$33.94
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2022
107 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q2 2022.
IRADIMED CORP - Common Stock (IRMD) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.47M shares
of 12.7M outstanding shares and own 42.98% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (726K shares), RENAISSANCE TECHNOLOGIES LLC (673K shares), Soleus Capital Management, L.P. (621K shares), BlackRock Inc. (415K shares), VANGUARD GROUP INC (379K shares), RK Capital Management, LLC (300K shares), Russell Investments Group, Ltd. (246K shares), Ranger Investment Management, L.P. (198K shares), ACADIAN ASSET MANAGEMENT LLC (166K shares), and DIMENSIONAL FUND ADVISORS LP (140K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.